NewAmsterdam Pharma Company NV (NAMS) EUR0.12

Sell:$28.20Buy:$40.50Price increased$1.48 (4.46%)

Prices delayed by at least 15 minutes
Sell:$28.20
Buy:$40.50
Change:Price increased$1.48 (4.46%)
Deal now
Prices delayed by at least 15 minutes
Sell:$28.20
Buy:$40.50
Change:Price increased$1.48 (4.46%)
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open$34.10
Previous close$33.20
Market cap$3.91bn
P/E ratio-99999.99
Volume649,125
Dividend yield0.00%
EMS-

Company information

NewAmsterdam Pharma Company NV is a Netherlands based company. NewAmsterdam Pharma operates as a clinical-stage company and focuses on the research and development of transformative oral therapies for major ...

  • LocationNetherlands
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyUSD
  • Shares in issue114.98m
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.